Eli Lilly Total Liabilities and Share Holders Equity 2010-2024 | LLY

Eli Lilly total liabilities and share holders equity for the quarter ending September 30, 2024 was $75.607B, a 30.55% increase year-over-year.

  • Eli Lilly total liabilities and share holders equity for 2023 was $64.006B, a 29.33% increase from 2022.
  • Eli Lilly total liabilities and share holders equity for 2022 was $49.49B, a 1.4% increase from 2021.
  • Eli Lilly total liabilities and share holders equity for 2021 was $48.806B, a 4.66% increase from 2020.

Eli Lilly Total Liabilities and Share Holders Equity 2010-2024 | LLY

  • Eli Lilly total liabilities and share holders equity for 2023 was $64.006B, a 29.33% increase from 2022.
  • Eli Lilly total liabilities and share holders equity for 2022 was $49.49B, a 1.4% increase from 2021.
  • Eli Lilly total liabilities and share holders equity for 2021 was $48.806B, a 4.66% increase from 2020.
Related Stocks
Company NameMarket
Cap
Novo Nordisk (NVO)$460.6B
Johnson & Johnson (JNJ)$368.4B
AbbVie (ABBV)$294.4B
Merck (MRK)$244.2B
Novartis AG (NVS)$211.1B
AstraZeneca (AZN)$197.8B
Pfizer (PFE)$142.2B
Sanofi (SNY)$121.8B
Innoviva (INVA)$1.2B